Tetralogy of Fallot (#7) — Postoperative Management

Early after TOF repair, the clinical course is most often determined by (1) RV diastolic “restriction,” (2) residual lesions, and (3) rhythm instability. The practical ICU message remains:

“The RV cannot fill the LV.”

If RV filling is limited, LV preload falls → systemic cardiac output drops, even when LV systolic function appears preserved.

1) The first 6–24 hours: what you are trying to “win”

1. Secure forward systemic output (LV preload is an RV problem)

• Maintain effective RV filling → adequate transpulmonary flow → LV preload
• Treat “numbers” (CVP/MAP) only in the context of flow and perfusion

2. Protect the RV (diastolic protection > aggressive inotropy)

• Avoid factors that worsen RV filling/afterload: tachycardia, hypoxia, hypercarbia, acidosis, high intrathoracic pressure
• Preserve AV synchrony (atrial contribution can be decisive)

3. Rapidly exclude residual lesions (physiology-driven, not pride-driven)

• RVOT obstruction, residual VSD, significant TR/PR, branch PA stenosis
• Early echo is not “documentation”—it is hemodynamic decision support

4. Prevent and treat postoperative tachyarrhythmias (JET = time-critical)

• JET can convert borderline physiology into LCOS within minutes by removing atrial kick and shortening diastole.

2) Restrictive RV physiology: the dominant early phenotype after TOF repair

What it looks like at the bedside

• High CVP with venous congestion plus low systemic output
• “Reasonable volume” but underfilled LV
• Marked sensitivity to ventilation changes (PEEP/mean airway pressure)

Why it happens (mechanistic)

• RV hypertrophy + ischemia/reperfusion + myectomy/ventriculotomy effects → stiff RV / poor compliance
• Doppler phenotype: end-diastolic forward flow into the PA, reflecting a “noncompliant RV” physiology that correlates with slower postoperative recovery. [1,2] (PubMed)
• Biologic correlate: restrictive physiology has been associated with myocardial injury markers (e.g., higher troponin) and oxidative stress, aligning with prolonged ICU recovery. [3] (AHA Journals)

Clinical implication (the “volume paradox”)

• Volume helps until it doesn’t.
• Give enough preload to open the RV
• But excess volume simply raises CVP → hepatic/renal congestion without improving LV filling

3) A practical, ICU-ready diagnostic sequence (Echo + Lines)

Step A — Confirm the “3 essentials” immediately

1. Rhythm: sinus vs JET; AV synchrony; rate-related underfilling
2. Residual lesion screen: RV pressure burden; RVOT gradient; residual shunt; valve regurgitation
3. Ventilation effect: is intrathoracic pressure limiting venous return and RV filling?

Step B — Echo questions that matter (repeat early, not “once a day”)

• RVOT: fixed vs dynamic narrowing; Doppler gradient; branch PA flows
• Patch line: residual VSD (direction + hemodynamic relevance)
• AV/PV competence: TR/PR severity and RV loading consequence
• Filling mechanics: septal position, LV underfilling, restrictive features

Key ICU integration: a rising CVP with falling output is not “more volume needed” until echo confirms the RV can accept it.

4) Management pillars (what to do, with physiologic intent)

4.1 Preload: “small bolus, rapid reassessment”

• 5–10 mL/kg aliquots with real-time response checks:
• MAP trend, lactate, ScvO₂/mixed venous, urine output
• Echo-based RV/LV filling and septal mechanics
• If CVP rises without output improvement: pivot early
• reduce intrathoracic pressure, restore AV synchrony, evaluate residual lesions, reconsider catecholamine escalation

4.2 Pulmonary vascular tone & ventilation: protect venous return and keep PVR low

• Avoid hypoxia, hypercarbia, acidosis, hypothermia-related vasoconstriction
• Ventilation strategy in restrictive RV physiology:
• avoid unnecessarily high PEEP/mean airway pressure (venous return/RV filling penalty)
• prevent atelectasis that drives PVR and RV afterload

4.3 Vasoactives: support “RV→lung→LV handoff,” avoid the tachycardia spiral

• If true low output with adequate filling: consider inotropy
• If high CVP + low output: prioritize filling mechanics + rhythm + residual lesion correction before simply escalating catecholamines
• Avoid “tachycardia spiral”:
• tachycardia → less diastolic filling → worse output → more catecholamine → worse tachycardia

5) Residual lesions: assume they exist until you prove they don’t

Residual defects are not “minor findings” in this physiology—they define the postoperative trajectory.

Common high-impact residual problems

• Residual RVOT obstruction: persistent RV pressure load mimics RV failure physiology
• Residual VSD: steals effective forward flow and adds volume burden
• TR/PR: worsens RV efficiency and venous congestion
• Branch PA stenosis: raises RV afterload and reduces pulmonary flow distribution

A modern “quality lens” (useful language for teams)

• Multicenter data across congenital operations show that major residual lesions are independently associated with worse early outcomes, supporting a low threshold for timely re-intervention when physiology demands it. [10] (ncbi.nlm.nih.gov)
• For TOF specifically, technical-performance frameworks based on predischarge echo similarly emphasize that “major residua” identify patients at increased early risk, reinforcing the clinical principle: persistent LCOS deserves a structural explanation until proven otherwise. [11]

6) Arrhythmias: JET after TOF repair is a physiologic emergency

Why JET is uniquely dangerous here

• Loss of AV synchrony + shortened diastole → catastrophic RV underfilling in an already stiff RV
• Large cohort experience shows JET is associated with substantially prolonged ventilation and ICU stay after congenital repairs (with TOF as a major contributor). [4] (OUP Academic)

JET “first-line bundle” (prevention + immediate treatment)

1. Sedation/analgesia (reduce catecholamine drive)
2. Correct electrolytes (Mg/K in particular)
3. Controlled cooling when appropriate
4. Reduce pro-arrhythmic inotrope load if feasible
5. Restore AV synchrony: atrial pacing / AV sequential pacing when possible
6. Antiarrhythmics per institutional pathway (commonly amiodarone/procainamide; β-blockade strategies have also been reported in selected pathways) [9]

7) Who is at higher risk for prolonged ICU course?

Across institutional series, younger age and lower weight repeatedly associate with longer ICU stay and morbidity after primary TOF repair, which is clinically consistent with smaller, less compliant RVs and narrower physiologic reserve. [6–8] (PubMed)

8) ICU “post-TOF repair” checklist (compact, bedside-ready)

• Perfusion: MAP trend, lactate, ScvO₂/mixed venous, urine output
• Filling pressures: CVP trajectory + congestion signs
• Rhythm: sinus vs JET; AV synchrony; pacing plan available
• Echo targets: RVOT gradient, residual VSD, TR/PR, RV/LV filling, septal position
• Ventilation: avoid excessive PEEP; prevent hypoxia/hypercarbia/acidosis
• Escalation triggers: persistent LCOS, high RV pressure burden, echo-confirmed significant residual lesions → early cath/surgical re-evaluation

References

[1] Cullen S, Shore D, Redington A. Characterization of right ventricular diastolic performance after complete repair of tetralogy of Fallot. Restrictive physiology predicts slow postoperative recovery. Circulation. 1995;91(6):1782-1789.

[2] Norgård G, Gatzoulis MA, Moraes F, Lincoln C, Shore DF, Shinebourne EA, et al. Relationship between type of outflow tract repair and postoperative right ventricular diastolic physiology in tetralogy of Fallot. Implications for long-term outcome. Circulation. 1996;94(12):3276-3280.

[3] Chaturvedi RR, Shore DF, White PA, Scallan MH, Redington AN. Acute right ventricular restrictive physiology after repair of tetralogy of Fallot: Association with myocardial injury and oxidative stress. Circulation. 1999;100(14):1540-1547.

[4] Dodge-Khatami A, Miller OI, Anderson RH, Gil-Jaurena JM, Goldman AP, de Leval MR. Impact of junctional ectopic tachycardia on postoperative morbidity following repair of congenital heart defects. Eur J Cardiothorac Surg. 2002;21(2):255-259.

[5] Paluszek C, Brenner P, Pichlmaier M, Haas NA, Dalla-Pozza R, Hagl C, Hakami L. Risk Factors and Outcome of Post Fallot Repair Junctional Ectopic Tachycardia (JET). World J Pediatr Congenit Heart Surg. 2019;10(1):50-57.

[6] Egbe AC, Mittnacht AJ, Nguyen K, Joashi U. Risk factors for morbidity in infants undergoing tetralogy of fallot repair. Ann Pediatr Cardiol. 2014;7(1):13-18.

[7] Egbe AC, Uppu SC, Mittnacht AJC, Joashi U, Ho D, Nguyen K, Srivastava S. Primary tetralogy of Fallot repair: predictors of intensive care unit morbidity. Asian Cardiovasc Thorac Ann. 2014;22(7):794-799.

[8] Egbe AC, Nguyen K, Mittnacht AJ, Joashi U. Predictors of Intensive Care Unit Morbidity and Midterm Follow-up after Primary Repair of Tetralogy of Fallot. Korean J Thorac Cardiovasc Surg. 2014;47(3):211-219.

[9] Affolter JT, Well A, Gottlieb EA, Fraser CD Jr. Routine perioperative esmolol after infant tetralogy of fallot repair: single-center retrospective study of hemodynamics. Pediatr Crit Care Med. 2022;23(12):e583-e589.

[10] Nathan M, Levine JC, Van Rompay MI, Lambert LM, Trachtenberg FL, Colan SD, et al. Impact of Major Residual Lesions on Outcomes After Surgery for Congenital Heart Disease. J Am Coll Cardiol. 2021;77(19):2382-2394.

[11] Alifu A, Wang H, Chen R. Technical performance scores associate with early prognosis of tetralogy of Fallot repair. Front Pediatr. 2024;12:1274913.